Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study

Keratinocytes (KCs) from healthy donors stimulated with type 2 cytokines are often used to experimentally study atopic dermatitis (AD) inflammatory responses. Owing to potential intrinsic alterations, it seems favorable to use KCs from patients with AD. KCs isolated from hair follicles offer a nonin...

Full description

Saved in:
Bibliographic Details
Main Authors: Hila Emmert, Franziska Rademacher, Matthias Hübenthal, Regine Gläser, Hanne Norsgaard, Stephan Weidinger, Jürgen Harder
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:JID Innovations
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667026724000560
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545951506857984
author Hila Emmert
Franziska Rademacher
Matthias Hübenthal
Regine Gläser
Hanne Norsgaard
Stephan Weidinger
Jürgen Harder
author_facet Hila Emmert
Franziska Rademacher
Matthias Hübenthal
Regine Gläser
Hanne Norsgaard
Stephan Weidinger
Jürgen Harder
author_sort Hila Emmert
collection DOAJ
description Keratinocytes (KCs) from healthy donors stimulated with type 2 cytokines are often used to experimentally study atopic dermatitis (AD) inflammatory responses. Owing to potential intrinsic alterations, it seems favorable to use KCs from patients with AD. KCs isolated from hair follicles offer a noninvasive approach to investigate AD-derived KCs. To evaluate whether such AD-derived KCs are suitable to mimic AD inflammatory responses, we compared hair follicle–derived KCs from healthy donors with those from patients with AD in a type 2 cytokine environment. Stimulation of AD-derived KCs with IL-4 and IL-13 induced higher expression changes of AD-associated markers than that of healthy KCs. The combination of IL-4 and IL-13 generally induced highest expression changes, but IL-13 alone also induced significant changes of AD-specific markers. Similar to the 2-dimensional cultures, IL-4/IL-13 stimulation of 3-dimensional skin models generated with AD-derived KCs modulated the expression of several AD-relevant factors. Whole-transcriptome analysis revealed that IL-4 and IL-13 acted similarly on these 3-dimensional skin models. Histologically, IL-13 alone and in combination with IL-4 increased epidermal spongiosis, a histological hallmark of AD skin. Taken together, our pilot study suggests that hair follicle–derived KCs from patients with AD represent a useful model system to study AD-related inflammation in a personalized in vitro model.
format Article
id doaj-art-f9b8d10e86e64564b06ff0e18e29e03f
institution Kabale University
issn 2667-0267
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series JID Innovations
spelling doaj-art-f9b8d10e86e64564b06ff0e18e29e03f2025-01-11T06:42:09ZengElsevierJID Innovations2667-02672025-01-0151100309Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot StudyHila Emmert0Franziska Rademacher1Matthias Hübenthal2Regine Gläser3Hanne Norsgaard4Stephan Weidinger5Jürgen Harder6Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Translational Sciences, Research & Early Development, LEO Pharma, Ballerup, DenmarkDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany; Correspondence: Jürgen Harder, Department of Dermatology, Quincke Research Center, Kiel University, Rosalind-Franklin Street 7, Kiel 24105, Germany.Keratinocytes (KCs) from healthy donors stimulated with type 2 cytokines are often used to experimentally study atopic dermatitis (AD) inflammatory responses. Owing to potential intrinsic alterations, it seems favorable to use KCs from patients with AD. KCs isolated from hair follicles offer a noninvasive approach to investigate AD-derived KCs. To evaluate whether such AD-derived KCs are suitable to mimic AD inflammatory responses, we compared hair follicle–derived KCs from healthy donors with those from patients with AD in a type 2 cytokine environment. Stimulation of AD-derived KCs with IL-4 and IL-13 induced higher expression changes of AD-associated markers than that of healthy KCs. The combination of IL-4 and IL-13 generally induced highest expression changes, but IL-13 alone also induced significant changes of AD-specific markers. Similar to the 2-dimensional cultures, IL-4/IL-13 stimulation of 3-dimensional skin models generated with AD-derived KCs modulated the expression of several AD-relevant factors. Whole-transcriptome analysis revealed that IL-4 and IL-13 acted similarly on these 3-dimensional skin models. Histologically, IL-13 alone and in combination with IL-4 increased epidermal spongiosis, a histological hallmark of AD skin. Taken together, our pilot study suggests that hair follicle–derived KCs from patients with AD represent a useful model system to study AD-related inflammation in a personalized in vitro model.http://www.sciencedirect.com/science/article/pii/S26670267240005603D skin modelsAtopic dermatitisHair follicle–derived keratinocytesIL-13IL-4
spellingShingle Hila Emmert
Franziska Rademacher
Matthias Hübenthal
Regine Gläser
Hanne Norsgaard
Stephan Weidinger
Jürgen Harder
Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
JID Innovations
3D skin models
Atopic dermatitis
Hair follicle–derived keratinocytes
IL-13
IL-4
title Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
title_full Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
title_fullStr Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
title_full_unstemmed Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
title_short Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
title_sort type 2 cytokine dependent skin barrier regulation in personalized 2 dimensional and 3 dimensional skin models of atopic dermatitis a pilot study
topic 3D skin models
Atopic dermatitis
Hair follicle–derived keratinocytes
IL-13
IL-4
url http://www.sciencedirect.com/science/article/pii/S2667026724000560
work_keys_str_mv AT hilaemmert type2cytokinedependentskinbarrierregulationinpersonalized2dimensionaland3dimensionalskinmodelsofatopicdermatitisapilotstudy
AT franziskarademacher type2cytokinedependentskinbarrierregulationinpersonalized2dimensionaland3dimensionalskinmodelsofatopicdermatitisapilotstudy
AT matthiashubenthal type2cytokinedependentskinbarrierregulationinpersonalized2dimensionaland3dimensionalskinmodelsofatopicdermatitisapilotstudy
AT regineglaser type2cytokinedependentskinbarrierregulationinpersonalized2dimensionaland3dimensionalskinmodelsofatopicdermatitisapilotstudy
AT hannenorsgaard type2cytokinedependentskinbarrierregulationinpersonalized2dimensionaland3dimensionalskinmodelsofatopicdermatitisapilotstudy
AT stephanweidinger type2cytokinedependentskinbarrierregulationinpersonalized2dimensionaland3dimensionalskinmodelsofatopicdermatitisapilotstudy
AT jurgenharder type2cytokinedependentskinbarrierregulationinpersonalized2dimensionaland3dimensionalskinmodelsofatopicdermatitisapilotstudy